CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc. Did you lose money on investments in Charles River? If so, please visit Charles River Laboratories International, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...

DEADLINE ALERT for SWK, VTRS, and CRL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders LOS ANGELES, May 22, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – CRL NEW YORK, Feb. 25, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Charles...

Global Drug Discovery Informatics Market – Driven By Growing R&D Expenditure, Rising Support For Research, Particularly In The Area Of Rare Diseases, And The Growing Use Of Informatics In Drug Discovery Covina, CA, July 20, 2020 (GLOBE NEWSWIRE) -- The report "Global Drug Discovery Informatics Market, By Solution (Software and Services), By Function (Sequencing & Target Data Analysis,...

Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. (CRL) on Behalf of Stockholders and Encourages CRL Investors to Contact the Firm NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Charles River Laboratories International, Inc. (NYSE: CRL).  Our investigation...